Synopsis
Sun Pharmaceutical Industries reported a net profit of Rs 3,117.95 crore for Q2 FY26, a 2.6% year-on-year increase. Revenue from operations grew 8.6% to Rs 14,405.22 crore, with U.S. Innovative Medicines sales surpassing Generics for the fir…

